13087 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Levine
    Levine
  4. Zelenetz
    Zelenetz
  5. Horwitz
    Horwitz
  6. Abdel-Wahab
    Abdel-Wahab
  7. Scheinberg
    Scheinberg
  8. Jakubowski
    Jakubowski
  9. Landau
    Landau
  10. Shah
    Shah

Groups

  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)
  7. Lymphoma (2639)
  8. Sloan Kettering Institute Faculty (2602)
  9. Executive Committee, Center for Hematologic Malignancies (2358)
  10. Survivorship Research (2328)
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Micafungin versus posaconazole anti-fungal prophylaxis in adult patients with acute leukemia undergoing induction chemotherapy
    Meeting Abstract

    Halton, E.; Chung, D.; Xiao, K.; Quintanilla, H.; Baldwin, C.; Baird, P.; Berman, E.; Brentjens, R. J.; Heaney, M.; Jurcic, J. G.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • EBMT risk score for pre transplant risk assessment in patients with multiple myeloma
    Meeting Abstract

    Gul, Z.; Khan, H.; Bashir, Q.; Shah, N.; Parmar, S.; Dinh, Y. T.; Hosing, C. M.; Popat, U. R.; Kebriaei, P.; Anderlini, P.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Cardiac toxicity after high-dose melphlan and autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Gul, Z.; Bashir, Q.; Nieto, Y.; Sherwani, N.; Parmar, S.; Shah, N.; Dinh, Y. T.; Hosing, C. M.; Popat, U. R.; Kebriaei, P.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • CD19-targeted donor T cells exert potent graft versus lymphoma activity and attenuated GVHD
    Meeting Abstract

    Ghosh, A.; Davila, M. L.; Young, L. F.; Kloss, C.; Gunset, G.; Smith, O. M.; West, M. L.; Singer, N. V.; Holland, A. M.; Jenq, R. R.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE): First detailed report of primary treatment
    Meeting Abstract

    Foss, F. M.; Carson, K. R.; Pinter-Brown, L.; Horwitz, S. M.; Rosen, S. T.; Pro, B.; Federico, M.; Gisselbrecht, C.; Hsi, E. D.
    Blood (2012)

    Fulltext@MSK | Save
  • Clinical safety and activity in a phase 1 trial of IPI-145, a potent inhibitor of phosphoinositide-3-Kinase-δ,γ, in patients with advanced hematologic malignancies
    Meeting Abstract

    Flinn, I. W.; Horwitz, S. M.; Patel, M.; Younes, A.; Porter, J. R.; Sweeney, J.; Allen, K.; Kelly, P.; Kahl, B. S.
    Blood (2012)

    Fulltext@MSK | Save
  • Brentuximab vedotin administered concurrently with multi-agent chemotherapy as frontline treatment of ALCL and other CD3O-positive mature T-cell and NK-cell lymphomas
    Meeting Abstract

    Fanale, M. A.; Shustov, A. R.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R. W.; Davies, A.; Midge, T.; Kennedy, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Pharmacokinetics and pharmacodynamics of IPI-145, a potent inhibitor of phosphoinositide-3-Kinase-δ,γ, following single- and multiple-dose administration in healthy subjects and patients with advanced hematologic malignancies
    Meeting Abstract

    Dunbar, J.; Nevejans, J.; McKee, C.; Faia, K.; van Lier, J. J.; Pruim, P.; Stegehuis, J.; Zhao, S.; Kahl, B. S.; Horwitz, S. M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Age-related thymic involution triggers intrinsic regeneration pathways but they remain ineffective for its renewal
    Meeting Abstract

    Dudakov, J. A.; Hanash, A. M.; Singer, N. V.; West, M. L.; Young, L. F.; Jenq, R. R.; Boyd, R. L.; Van Den Brink, M.
    Blood (2012)

    Fulltext@MSK | Save